精密腫瘍治療のための誘導リボヌクレアースターゲティングキメラによるG-クアドルプレックスmRNAの静止
Yuan Zhang1, Lingyan Wang1, Fenglin Wang1
1State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan 410082, China.
Journal of the American Chemical Society
|June 4, 2024
まとめ
誘導性RIBOTAC (iRIBOTAC) は,がん治療のためのG四重複 (G4) RNAの標的分解を可能にします. この新しいアプローチは,精密なG4RNAサイレンシングと腫瘍抑制のためのバイオオートゴーナルまたは細胞特異のトリガーを使用します.
科学分野:
- 生物化学
- 分子生物学
- ガン 治療
背景:
- リボヌクレアースターゲティングキメラ (RIBOTAC) は新興の標的療法戦略である.
- RIBOTACの選択的活性化については,バイオオートゴーナルまたは細胞特異のトリガーによって,まだ研究されていない.
研究 の 目的:
- 誘導可能なRIBOTAC (iRIBOTAC) を開発し,G-四重複 (G4) RNAをオンデマンドで分解する.
- 制御されたG4RNAサイレンスによる 精度の高いがん治療を可能にします
主な方法:
- 近赤外線 (NIR) 光G4リガンドを非競争性G4リガンドと結合することによって,二価G4結合剤を設計した.
- G4結合剤をケージリボヌクレアースリクルーターと結合し,バイオオルトゴン反応,腫瘍特異な酵素,または代謝産物によって分解する.
- iRIBOTACの活性化後の遺伝子発現の変化を分析するためにRNA配列を活用した.
主要な成果:
- iRIBOTACによる特定の刺激に対するG4RNAのノックダウンが実証された.
- 細胞破壊,チャネル調節,代謝に関連する遺伝子発現の異常を観察した.
- マウスモデルでアポトーシスの有意な誘導と選択的な腫瘍増殖抑制が確認された.
- NIR光を用いた選択的腫瘍イメージングの能力を示した.
結論:
- iRIBOTACは,誘導可能なG4RNAのターゲティングとサイレンシングを可能にすることで,がん治療の貴重なパラダイムを表しています.
- この戦略は,バイオオートゴーナルまたは腫瘍特有のトリガーを用いて,G4RNAの分解を正確に制御することを可能にします.
- iRIBOTACは選択的な腫瘍イメージングと成長抑制を容易にし,治療の可能性を強調しています.
関連する概念動画
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K


